[ad_1] The Kenyan Ministry of Health has banned the prescription of Dolugravir (DTG), a first-line drug against HIV-AIDS, because it could be badociated with conbad malformations in HIV-positive women
Read More »Kenya bans the use of the anti-HIV drug Dolutegravir by pregnant and lactating women
